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Abstract
Schwann cells (SCs) have been considered to be one of the most promising cell types for 
transplantation to treat spinal cord injury (SCI) due to their unique growth-promoting properties. 
Despite the extensive use as donor cells for transplantation in SCI models, the fate of SCs is 
controversial due in part to the lack of a reliable marker for tracing the grafted SCs. To precisely 
assess the fate and temporal profile of transplanted SCs, we isolated purified SCs from sciatic 
nerves of adult transgenic rats overexpressing GFP (SCs-GFP). SCs-GFP were directly injected 
into the epicenter of a moderate contusive SCI at the mid-thoracic level at 1 wk post-injury. The 
number of SCs-GFP or SCs-GFP labeled with Bromodeoxyuridine (BrdU) was quantified at 5 
min, 1 d, and 1, 2, 4, 12 and 24 wk after cell injection. Basso, Beattie, and Bresnahan (BBB) 
locomotor rating scale, footfall error, thermal withdrawal latency, and footprint analysis were 
performed before and after the SCs-GFP transplantation. After transplantation, SCs-GFP quickly 
filled the lesion cavity. A remarkable survival of grafted SCs-GFP up to 24 wk post-grafting was 
observed with clearly identified SC individuals. SCs-GFP proliferated after injection, peaked at 2 
wk (26% of total SCs-GFP), decreased thereafter, and ceased at 12 wk post-grafting. Although 
grafted SCs-GFP were mainly confined within the border of surrounding host tissue, they 
migrated along the central canal for up to 5.0 mm at 4 wk post-grafting. Within the lesion site, 
grafted SCs-GFP myelinated regenerated axons and expressed protein zero (P0) and myelin basic 
protein (MBP). Within the SCs-GFP grafts, new blood vessels were formed. Except for a 
significant decrease of angle of rotation in the footprint analysis, we did not observe significant 
behavioral improvements in BBB locomotor rating scale, thermal withdrawal latency, or footfall 
errors, compared to the control animals that received no SCs-GFP. We conclude that SCs-GFP can 
survive remarkably well, proliferate, migrate along the central canal, and myelinate regenerated 
axons when being grafted into a clinically-relevant contusive SCI in adult rats. Combinatorial 
strategies, however, are essential to achieve a more meaningful functional regeneration of which 
SCs may play a significant role.
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Introduction
Spinal cord injury (SCI) results in the destruction of descending motor and ascending 
sensory pathways leading to permanent damage with limited prospects for spontaneous 
repair (Bradbury and McMahon, 2006; Thuret et al., 2006). The failure of injured axons to 
regenerate results from a combination of factors including the lack of permissive growth 
substrates at lesion sites, the presence of inhibitory molecules that impair axonal outgrowth 
(Filbin, 2003; Silver and Miller, 2004; Yiu and He, 2006), the lack of neurotrophic support 
(Bradbury et al., 1999; Iannotti et al., 2003), and the death of oligodendrocytes that induces 
demyelination of surviving axons (Crowe et al., 1997; Liu et al., 1997; Totoiu and Keirstead, 
2005). Since cavity or gap formation is evident following SCI in rats and humans (Oudega 
and Xu, 2006; Xu and Onifer, 2009), cell transplantation into the lesion site is essential to 
provide permissive substrates for axonal extension through and beyond it. Different cell 
types, including neural stem cells (NSCs) (Fujimoto et al., 2012; Sandner et al., 2012), fate-
restricted neural and glial precursors (NRPs and GRPs) (Cao et al., 2002; Hill et al., 2004; 
Mitsui et al., 2005), Schwann cells (SCs) (Deng et al., 2011; Xu et al., 1997; Xu et al., 
1995b), olfactory ensheathing glial cells (OEGs) (Feron et al., 2005; Ma et al., 2010), and 
marrow stroma cells (MSCs) (Ding et al., 2011; Phinney and Isakova, 2005) have been used 
as donor cells for transplantation after SCI with variable degrees of success. Importantly, 
genetic modification of transplanted cells could be utilized for gene therapy to enhance 
morphological and functional restoration (Deng et al., 2011; Girard et al., 2005).
SCs are the myelin-forming cells of the peripheral nervous system, and have been shown to 
improve functional recovery not only by myelinating axons after transplantation into the 
injured spinal cord, but also by forming a permissive substrate and producing growth-
promoting factors and cell adhesion molecules (Hu et al., 2011; Oudega and Xu, 2006; Xu 
and Onifer, 2009) for regenerating axons. For example, SCs injected into a 1-wk-old 
moderate contusive SCI promoted axon regeneration into the transplant and improved 
hindlimb locomotion (Takami et al., 2002). Our previous studies showed that transplanted 
SCs in guidance channels successfully bridged the injured spinal cord and promoted axonal 
regeneration across the lesion gap following SCI (Deng et al., 2011; Xu, 1996; Xu et al., 
1997; Xu et al., 1995b). The fate of grafted SCs, however, was not clear and is controversial 
in the field due in part to the lack of a reliable marker to trace the grafted SCs. For instance, 
Hill et al. reported that SCs survive poorly within a moderately contusive spinal cord 
environment. A 7-d delay in transplantation improves their survival, but the majority of SCs 
still die soon after grafting (Hill et al., 2006).
Here we transplanted SCs isolated from transgenic adult rats expressing green fluorescent 
protein (SCs-GFP) into a lesion cavity at 1 wk after a moderate contusive SCI at the thoracic 
level in adult rats to examine the fate and temporal profile of grafted SCs. We also examined 
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migration, proliferation, and apoptosis in these cells. We concluded that grafted SCs-GFP 
survive well for a considerable time after being grafted into the injured spinal cord. They 
proliferate, migrate along the central canal, support axonal regeneration, and myelinate 
regenerated axons within the lesion site. The lack of substantial behavioral recovery after 
SCs-GFP transplantation emphasizes the need of combinatorial strategies to achieve a more 
meaningful functional regeneration after SCI.
Materials and Methods
Animals
A total of 4 transgenic adult rats expressing green fluorescent protein (GFP) and 56 female 
Sprague Dawley (SD) adult rats (Harlan Co; Indianapolis, IN) weighting 200 to 220 g were 
used in this study. GFP transgenic adult rats (Rosa 26, SD strain, generous gift from George 
M. Smith, Temple University) were used for isolation and culture of SCs-GFP, whereas the 
remaining rats were used for SCI and transplantation studies. Among the 56 SD rats, 42 
were assigned for assessing the survival, proliferation, migration, and myelination of grafted 
SCs-GFP, 12 were used for behavior tests, and 2 were used for long-term observation of 
grafted SCs-GFP. All animal care and surgical interventions were undertaken in strict 
accordance with the Public Health Service Policy on Humane Care and Use of Laboratory 
Animals, Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal 
Resources, National Research Council), and were approved by the Indiana University 
Institutional Animal Care and Use Committee and Institutional Biosafety Committee.
Isolation and Culture of SCs-GFP
The methods for SCs isolation, purification, and amplification were developed by Morrissey 
et al. (Morrissey et al., 1991) and described in our previous publications (Deng et al., 2011; 
Hu et al., 2013; Xu et al., 1995a; Xu et al., 1995b). Briefly, sciatic nerves were obtained 
from GFP transgenic adult rats anaesthetized with ketamine (87.7 mg/kg; Ben Venue Labs, 
OH) and xylazine (12.3 mg/kg; Butler, OH) under aseptic conditions. After epineurium and 
connective tissue were removed, the nerves were cut into 1-mm-long explants. The explants 
were placed in 35-mm tissue culture dishes (Baxter, Stone Mountain, GA, USA) with low 
levels (0.8 mL) of Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS; Life Technologies, Grand Island, NY, USA). When the outgrowth 
of migratory cells (predominantly fibroblasts) reached a near-confluent monolayer around 
the explants (7 d), the explants were transferred to new culture dishes with fresh medium. 
After 5 to 6 such passages (5–6 wk), the cells that emerged from the explants were primarily 
SCs. The explants were then transferred to a 35-mm dish containing 1.25 U/mL dispase 
(Boehringer Mannheim Biochemicals, Indianapolis, IN, USA), 0.05% collagenase 
(Worthington Biochemicals Corp., Freehold, NJ, USA) and 15% FBS in DMEM for 
incubation overnight at 37°C in 5% CO2. On the following day, the explants were 
dissociated and the cells were plated onto poly-L-lysine-coated 100-mm dishes in 
DMEM/10% FBS. Later, the cultures were re-fed with the same medium supplemented with 
20 μg/mL pituitary extract (BTI, Stoughton, MA, USA) and 2 μM forskolin (Sigma, St 
Louis, MO, USA) for dividing. When the SCs reached confluence, they were rinsed in Ca2+- 
and Mg2+- free Hanks balanced salt solution (CMF-HBSS; Life Technologies, USA) and 
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briefly treated with 0.05% trypsin (Life Technologies, USA) and 0.02% EDTA (Life 
Technologies, USA) in CMF-HBSS. Cells were washed twice in DMEM/10% FBS and 
passed into new dishes at a density of 2 × 106 cells/100 mm dish. The purity of the SCs 
(Percentage of P75+GFP+ cells in all GFP+ cells) was quantified according to the methods 
described previously (Xu et al., 1995b). All SCs used in this study were passage (P) 2 cells 
with a purity of > 98%.
Moderate thoracic contusion injury
Moderate contusion injury was induced by a weight drop device developed at New York 
University called NYU impactor (Gruner, 1992). A laminectomy was performed at the 
thoracic vertebrae 8 exposing the dorsal surface of the 9th thoracic spinal cord (T9) 
underneath without disrupting the dura mater. The exposed spinal cord was injured by 
dropping a 10.0-g rod from a height of 12.5 mm. The contusion impact height, compression, 
and velocity were monitored. After injury, a fine dura suture at the epicenter of the injury 
area was made with 10-0 nylon and the injury was covered with a sterile piece of parafilm 
(Pechiney Plastic Packaging, Chicago, IL) as landmarks for the secondary surgery and cell 
injection. The muscles were sutured in layers and the skin was closed with clips. The rats 
were allowed to recover in a warmed cage with water and food easily accessible. The 
analgesic buprenorphine hydrochloride (0.01 mg/kg, Reckitt and Colman, Hull, UK) was 
subcutaneously delivered post-surgery and daily for 2 d.
SCs-GFP transplantation
SC transplantation was performed at 1 wk after SCI. Four hours prior to implantation, fresh 
DMEM/10% FBS medium containing 20 μg/mL pituitary extract and 2 μM forskolin was 
added to the culture. SCs-GFP were harvested from culture via trypsinization, centrifuged, 
re-suspended, and counted (Hill et al., 2007). After counting, SCs-GFP were re-suspended 
as aliquots in DMEM/10% FBS medium supplemented with 20 μg/mL pituitary extract and 
2 μM forskolin and were kept on ice prior to grafting. Rats were re-anesthetized with 
ketamine and xylazine, as described above, and the injury site was re-exposed. A total of 
1×106 SCs-GFP, suspended in 5 μL of culture medium, were directly injected into the lesion 
cavity, identified by the 10-0 nylon suture on the dura surface. The injection was made using 
pulled glass capillaries attached to a pneumatic pump device at a speed of 0.1 μL/sec. The 
injection pipette was kept in place for an additional 3 min to minimize leakage upon 
withdrawal. After the injection, the muscle and the skin were closed in layers and animals 
received postoperative care according to our standard protocol (Xu et al., 1997; Xu et al., 
1995a; Xu et al., 1995b). Injury-only controls received 5 μL of culture medium injections. 
All animals received a daily subcutaneous injection of cyclosporine A (CsA, 10mg/kg; 
Sigma) starting 3 d prior to the transplantation which was continued until the end of the 
experiments. In 2 rats that survived for 52 wk (~1 yr) after SCs-GFP transplantation, the rats 
received CsA treatment for only the first 3 months.
Pulse-labeling of the proliferating SCs following transplantation
To assess the proliferation of grafted SCs, one day before the termination of animals at each 
time point (except for the group sacrificed at 5 min post-transplantation), animals received 4 
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intraperitoneal injections of 5-bromo-2′-deoxyuridine (BrdU, Sigma, St. Louis, MO; 100 
mg/kg/injection) at every 6 h.
Histology
At indicated time points post-transplantation (Fig. 1), animals were deeply anesthetized with 
60 mg/kg pentobarbital and perfused transcardially with 100 mL heparinized saline followed 
by 4% paraformaldehyde (PFA) in phosphate buffer (PB; 0.01M, pH 7.4). The spinal cord 
segments containing the injury/transplant epicenter were removed, post-fixed in the same 
perfusion fixative for overnight at 4°C, and cryoprotected in 30% sucrose in phosphate-
buffered saline (PBS; 0.01M, pH 7.4) for another 5–7 d. A 2-cm-long spinal cord segment 
centered at the injury/transplant epicenter was dissected out. The cord segments were 
embedded in Tissue-Tek and sectioned longitudinally or transversely (a subset) at 20 μm in 
5 sets on a cryostat (Leica CM 1950). Sections were mounted onto gelatin-subbed slides and 
stored at −20°C for immunohistological analyses and quantification of grafted SCs-GFP.
Immunocytochemistry
For in vitro experiments, cells in culture were fixed in 4% PFA for 20 min prior to blocking/
permeabilization for immunocytochemistry with mouse anti-p75NTR antibody (Cell 
Signaling Technology, Danvers, MA) overnight followed by the rhodamine-conjugated 
donkey anti-mouse IgG (1:200; Jackson ImmunoResearch Lab, West Grove, PA) for 1 h at 
37°C. Mouse IgG control sera were used at the same concentration as the corresponding 
primary antibodies to establish the specificity of staining.
For in vivo experiments, every 5th sagittal section (100 μm apart) was immunochemically 
stained as previously described (Liu et al., 2008). The following primary antibodies were 
used: rabbit anti-glial fibrillary acidic protein to identify astrocytes (GFAP, 1:400; 
Chemicon, Temecula, CA), mouse anti-SMI-31 to recognize the phosphorylated 
neurofilament epitope of axons (1:200, Sigma), mouse anti-ED-1 to identify activated 
microglia/macrophages (1:400, Sigma), and mouse RECA-1 (R&D Systems, Minneapolis, 
MN, USA) to recognize blood vasculature. A mix of the monoclonal rabbit anti-
Neurofilament 200 antibody (1:200, Sigma) and one of the following antibodies: goat anti 
myelin protein zero (P0, 1:400) and mouse anti-myelin basic protein (SMI-94, 1:1,000, 
Covance), were used to determine the type of myelination on axons within the graft region. 
After the primary antibodies, sections were incubated with the corresponding secondary 
antibodies including AMCA-conjugated donkey anti-rabbit IgG, rhodamine-conjugated 
donkey anti-mouse IgG, or rhodamine-conjugated donkey anti-goat IgG (1:200; all from 
Jackson ImmunoResearch Lab) alone or in combination according to the primary antibodies 
used. After staining, the slides were rinsed with PBS and mounted with Gel/Mount aqueous 
mounting media contained with Hoechst 33342, a fluorescent nuclear dye.
For BrdU staining, a commercially available in situ BrdU incorporation assay was used. 
Briefly, sections were treated with 1 N HCl for 40 min at 37°C to denature the DNA prior to 
the use of primary rabbit anti-BrdU antibody (1:100; Sigma) overnight at 4°C and then 
secondary antibody (rhodamine-conjugated donkey anti-rabbit IgG; 1:200; Jackson 
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ImmunoResearch Lab) at room temperature for 2 h. The slides were rinsed with PBS and 
mounted with Gel/Mount aqueous mounting media containing Hoechst 33342.
To determine whether transplanted SCs underwent apoptosis, the terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) assay was performed using an In Situ Cell 
Death Detection Kit (Roche, Penzberg, Germany). In brief, after incubation in 
permeabilization solution containing 0.1% triton X-100 in 0.1% sodium citrate for 2 min, 
the slides were washed twice with PBS and incubated with 50 μL of TUNEL reaction 
solution for 1 h in a humidified chamber at 37 °C in the dark. The slides were rinsed with 
PBS and mounted with Gel/Mount aqueous mounting media containing Hoechst 33342.
Quantification of SCs-GFP survival, proliferation and apoptosis
Complete sets of every 5th section (20 μm thick, 100 μm apart) of the spinal cord segments 
containing grafted SCs-GFP were processed. Fluorescent images were acquired with a Zeiss 
Axiovert 200M fluorescent microscope in Z-stack mode and were deconvoluted with the 
Axiovision software package (Carl Zeiss) to obtain near-confocal quality optical sections. 
Merged images were post-processed using ImageJ (NIH, Bethesda, MD) to quantify the 
total number of SCs-GFP per 20 μm-thick section. Only GFP+ SCs that contained a clear 
nuclear dye Hoechst 33342 were recognized and counted. All BrdU+ SCs-GFP, representing 
proliferating grafted SCs, were photographed and counted manually in each 20 μm-thick 
section. Likewise, all TUNEL+ SCs-GFP, representing grafted SCs that underwent 
apoptosis, were counted manually in each 20 μm-thick section. The estimated total number 
of GFP+ SCs was calculated as: (the number of GFP+ SCs per section) x (the number of 
total sections per set) x (the number of sets). The estimated total number of BrdU+ SCs-GFP 
and TUNEL+ SCs-GFP was calculated in the same manner. The percentage of BrdU+ or 
TUNEL+ SCs-GFP in all grafted SCs-GFP at different time points was calculated by 
dividing the total number of BrdU+ or TUNEL+ SCs-GFP by the total number of SCs-GFP.
Assessment of maximum distance of SC migration
To assess the migratory ability of transplanted SCs-GFP within the injured spinal cord, all 
longitudinal sections that contained transplanted SCs-GFP in one set of sections were 
examined under an Olympus BX60 microscope. We measured the longest distance (mm) 
that the grafted SCs-GFP migrated from the rostral or caudal lesion border demarcated by 
the GFAP-labeled astrocytes on the border.
Behavioral testing
Rats for the behavioral assessments were randomly assigned to 2 groups: the control group 
received injections of culture medium alone and the transplantation group received 
injections of SCs-GFP. The Basso, Beattie, and Bresnahan (BBB) open-field locomotor 
rating scale was used to assess hindlimb locomotor recovery according to the previously 
published work (Basso et al., 1995). The tests were performed by two examiners who were 
blinded to the animals’ treatments at 1 d pre-injury (baseline, BL), 2 d after injury, and 1, 2, 
3, 4, 5, 6, 7, 8, 9, and 10 wk after injections of cells or medium. Animals with a minimum 
BBB score of 12 were further analyzed and included in the footprint and grid-walking 
analyses from the 3rd wk after cell transplantation.
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Footprint analysis was performed at different time points using a procedure described 
previously (Hu et al., 2013). The hindlimbs of the rats were dipped in nontoxic blue dyes 
and the animals walked on a paper-covered narrow runway (100 cm long and 7 cm wide). 
To perform the measurements, the first and last 15 cm of the prints were excluded to avoid 
analyzing the beginning and end of the limb movements. The angle of rotation (AOR) was 
assessed by measuring the angle between two lines connecting the third toe and the stride 
line at the center of the paw pad. The base of support was determined by measuring the 
distance between the central pads on the hind paws (DBF). Stride length (SL) was 
determined by measuring the linear distance between corresponding successive points of 
contact of the same foot. Paw length (PL) was determined by measuring the longest paw 
print. Toe spread (TS) was determined by measuring the distance between first and fifth toes 
based on the largest value attained for each side. The trial was repeated 3 times and the 
results were averaged for each rat.
Grid-walk analysis was performed to assess the deficits in descending motor functions 
(Metz et al., 2000) in a manner complementary to the footprint. The rats were allowed to 
traverse over a wire mesh grid (2.5 × 2.5 cm2 grid spaces). Animals were required to walk 
for at least 30 s on this device up to a 3-min test period during which the total number of 
hindlimb movements and the number of footfalls of the hindlimb were counted, 
respectively, by two examiners blind to the experiment. One footfall was defined when the 
hindlimb paw protruded entirely through the grid with all toes and heel extended below the 
wire surface. Data were expressed as the percentage of footfalls over the total number of 
hindlimb movement. For each session, the average number of paw falls of each rat was 
taken from 3 trials.
Thermal sensitivity was assessed by measuring latency to paw withdrawal from a noxious 
heat source, as described by Hargreaves et al (Hargreaves et al., 1988). Rats were allowed to 
acclimate within acrylic glass enclosures on a clear glass plate maintained at 30°C. A radiant 
heat source was focused through the glass plate onto the plantar surface of the both hind 
paws. Withdrawal latency was measured using a motion detector that shut off the heat 
stimulus and a timer on withdrawal of the paw. A maximal cutoff of 20 s was used to 
prevent tissue damage. Thermal sensitivity was measured at baseline, 2 d after SCI, and 
weekly post-cell transplantation.
Statistical analysis
One-way ANOVA followed by the Fisher’s least significant difference (LSD) post hoc test 
was used to determine statistical differences of the average number of SCs-GFP+ within the 
lesion site of a moderately contused spinal cord between animals sacrificed at different time 
points. However, in case of unequal variance (F test), a nonparametric analysis (Kruskal–
Wallis test followed by Mann–Whitney test) was used. Pearson’s Chi-square test was used 
to determine statistical differences of the percentage of BrdU+, or TUNEL+ SCs-GFP 
between animals terminated at different time points. A mixed factorial (repeated measures) 
ANOVA followed by the Tukey-Kramer test was used for comparison of weekly functional 
recovery (BBB and footprint) after injury. Differences were accepted to be statistically 
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significant at P < 0.05*, <0.01** and <0.001***. All errors are given as standard deviation 
of mean.
Results
Characterization of SCs-GFP in Vitro
Schwann cells isolated from transgenic adult rats expressing GFP (SCs-GFP) showed 
similar growth properties to SCs isolated from wild type adult rats. These cells exhibited 
spindle morphology and swirling cell pattern with parallel cell alignment when cultured on 
poly-L-lysine. Over 98% of these SCs expressed P75NTR, a marker for Schwann cells (Fig. 
1). Since the purpose of this study was to accurately assess SC survival, it was important to 
precisely establish the number of cells transplanted. A previous study, however, showed that 
the actual average number of SCs that passed through the glass needle was only about 
56.5% of the intended number of SCs (Hill et al., 2007). To eliminate this error from the 
calculation of percentage of surviving SCs, the actual number of cells present immediately 
after injury (5 min post-transplantation), instead of the intended number of cells, was 
considered the baseline value (100%) of grafted SCs-GFP.
Survival of grafted SCs-GFP up to 24 wk post-grafting in vivo
In all rats, the SCs-GFP transplant could be easily recognized under a fluorescence 
microscope because these cells expressed strong green fluorescence signal even at 1 y after 
transplantation. Morphological analysis revealed changes in the appearance of grafted SCs-
GFP over time (Fig. 2) as they integrated into the lesion site. At 5 min (Fig. 2A, H) after 
transplantation, SCs-GFP cells within the lesion site were spherical in shape. SCs with a 
bipolar shape, a sign of integration into the host tissue, were found in the transplant margins 
at 1 d (Fig. 2B, I) and throughout the transplant at 1 wk (Fig 2C, J). Between week 2 and 
week 24, SCs-GFP further elongated along the longitudinal axis of the spinal cord and 
arranged in an orderly fashion (Fig. 2D/K, E/L, 2F/M, and G/N). At 5 min post-
transplantation, an average of 8.12×105 cells/graft was observed. Although a significant 
decrease of the percent total number of SCs-GFP was detected at 1 d after grafting 
((6.42±0.52)×105, compared to 5 min, t=4.67, p=0.0012), a significant recovery 
((7.81±0.76) ×105, compared to 1 d, t=3.29, p=0.011) of the number of SCs-GFP was 
observed at 2 wk after transplantation (compare to 5 min, t=0.8, p=0.44). Thereafter, the cell 
number slightly decreased over a prolonged period of time and, at 24 wk after 
transplantation, (6.21±0.56)×105 grafted cells survived at the lesion site (compared to 2 wk, 
t=4.15, p=0.002) (Fig. 2O).
Proliferation of Grafted SCs-GFP in Vivo
To determine whether SC proliferation was a contributing factor to the total number of 
survived SCs-GFP within the lesion site of a moderately contused spinal cord, we examined 
and quantified the proliferation rate of SCs-GFP by BrdU pulse-labeling of proliferating 
SCs. One day after grafting, 5.47±0.84% of the grafted SCs-GFP was BrdU positive (Fig. 
3B). This proliferative rate increased slightly to 9.54±1.23% at 1 wk after injection (Fig. 3C, 
χ2=24708, p<0.001) and reached its peak at 25.91±2.21% at 2 wk post-grafting (Fig. 3D, 
χ2=402136, p<0.001), corresponding to the highest number of total SCs-GFP after cell 
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injection. The SCs-GFP proliferation decreased markedly at 4 wk post-grafting 
(6.13±0.49%, χ2=815, p<0.001, Fig. 3E). At 12 (0.07±0.00%, χ2=80570, p<0.001, Fig. 3F) 
or 24 wk post-grafting, few, if any, proliferating SCs-GFP were observed (Fig. 3H).
Lack of substantial apoptosis of grafted SCs-GFP in vivo
Apoptosis-induced cell death is an important possible mechanism for the loss of grafted 
cells. Although a few SCs-GFP were identified to be positively stained for TUNEL at 5 min 
post-grafting (0.17±0.06%, Fig. 4A, H), we did not observe substantial apoptosis of grafted 
SCs-GFP over a period of 24 wk post-grafting. Very few SCs-GFP cells were found to be 
apoptotic (TUNEL+) at 1 d post-grafting (0.03±0.02%, χ2=230819, p<0.001, Fig. 4B, H,) 
and no apoptotic cells were found between 1 wk (Fig. 4C) to 24 wk (Fig. 4D–G). These 
results strongly suggest that substantial apoptotic cell death did not occur in SCs-GFP after 
being grafted into the injured spinal cord, revealing another important contributing factor to 
the survival of SCs-GFP within the lesion site.
Migration of grafted SC cells after transplantation
Migration of SCs to host tissue may facilitate axonal growth from the graft into the host 
spinal cord. As early as 1 day following transplantation, SCs-GFP attempted to elongate 
from the lesion border (yellow dashed line) into the host tissue (Fig. 5A). Four weeks after 
grafting, SCs-GFP migration from the lesion border into the host tissue was found only in 
the rostral and/or caudal directions. In some cases, the SCs-GFP migrated into the host 
spinal cord for a longest distance of 3.0 mm (Fig. 5B) to 5.0 mm (Fig. 5C), often along 
enlarged central canal.
Myelination by grafted SCs in vivo
Except for the formation of a permissive substrate and provision of growth-promoting 
factors and cell adhesion molecules for regenerating axons, grafted SCs can myelinate 
regenerated axons. At 4 wk after transplantation, grafted SCs-GFP exhibited a close 
association with SMI-31+ axons at the lesion site (Fig. 6A). Longitudinal (Fig. 6B–D) and 
cross sectional (Fig. 6E–G) confocal images clearly show that grafted SCs-GFP twined 
around and/or wrapped SMI-31+ axons that had grown into that region. Three months after 
transplantation, triple fluorescence staining showed that protein zero-positive (P0+, Fig. 6H–
K) and myelin basic protein-positive (MBP+, Fig. 6L–O) mature myelin was formed by 
SCs-GFP cells. Interestingly, with the increase of P0 and MBP signals, the fluorescence 
intensity of GFP decreased, making the blurry observation of the co-localization of P0/GFP 
and MBP/GFP.
Blood vessel formation after SCs-GFP transplantation
Blood supply to the graft and growing axons at the lesion site are critical for meaningful 
transplantation-mediated repair. We therefore examined the newly formed blood vessels 
among different groups. In the group that received no cell transplantation, contusive SCI 
resulted in the development of a well-defined large cystic cavity at the lesion site at 3 mo 
post-grafting. REAC+ blood vessels distributed within the host tissue surrounding the cavity 
and no REAC+ blood vessels were found within the lesion cavity (Fig. 7A, C). When SCs-
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GFP were transplanted into the lesion site, a few REAC+ blood vessels could be found in the 
SCs-GFP graft as early as 1 wk post-transplantation (Fig. 7F) and maintained throughout all 
time points up to 24 wk post-transplantation (Fig. 7G–J). These vessels might play important 
roles in providing substantial nutritional support for the grafted SCs.
Locomotor and sensory assessments after SCs-GFP transplantation
Twelve rats were randomly selected for behavior testing after SCI and then were randomly 
assigned to 2 groups including the SCs-GFP transplantation and non-transplantation 
(medium only) groups. All animals exhibited a gradual improvement in hindlimb locomotor 
function, measured using the BBB locomotor rating scale, during the 10-wk period after cell 
transplantation (Fig. 8A). In 2 experimental groups, most rats exhibited frequent to 
consistent weight-supported plantar stepping and occasional (BBB score of 12) to frequent 
(BBB score of 13) forelimb–hindlimb coordination at 3 wk when they were eligible for grid 
walking and footprint tests. However, up to 10 wk post-transplantation, we did not observe 
significant differences in BBB locomotor rating scale (Fig. 8A), footfall errors (Fig. 8B), 
and paw withdraw latency (Fig. 8C) between the 2 groups. Although we also did not observe 
significant difference in total spread (Fig. 8E), paw length (Fig. 8F), stride length (Fig. 8G), 
and base of support (Fig. 8H) of the foot print analysis between the 2 groups, we did find an 
improvement in angle of rotation of the SCs-GFP transplantation group compared to the 
control group after 8 wk post-transplantation (Fig. 8D, p<0.05).
Long-term survival of grafted SCs-GFP: a need for immunosuppression
We have observed remarkable survival of grafted SCs-GFP up to 24 wk post-transplantation 
with the application of the immunosuppressive drug CsA. To verify the importance of 
immunosuppression for long-term survival of grafted SCs, CsA immunosuppression of 2 
animals was withdrawn at 3 mo after the SCs-GFP transplantation and the animals were 
allowed to survival for additional 9 mo (i.e., up to 1 y after transplantation). We observed 
that numerous GFP+ SCs survived and filled in the lesion cavity in an orderly orientation 
(Fig. 9A, B) indicating long-term survival of grafted SCs, at least for 1 y in rats, can be 
achieved. Notably, ample ED1+ macrophages (Fig. 9E) were found, not only in areas around 
the transplant but also in the adjacent host tissue and for considerable distances particularly 
in the rostral and caudal directions. These macrophages were GFP+ (Fig. 9C, F) indicating 
that they might have phagocytized exogenously grafted SCs-GFP to become fluorescent 
green and then migrated out from the lesion site. These results clearly indicated that 
consistent immunosuppression is required for long-term survival of grafted SCs-GFP and for 
preventing secondary damage induced by invasion of macrophages and/or activation of 
microglia.
Discussion
In the present study, SCs-GFP were transplanted into the spinal cord at 1 wk after a 
moderate contusive SCI. We found a remarkable survival of grafted SCs-GFP up to 1 y 
post-grafting. The grafted SCs-GFP proliferated, peaked at 2 wk post-transplantation, and 
gradually decreased at 4 wk and thereafter. SCs-GFP migration from the lesion border into 
the host tissue was found only in the rostral and/or caudal directions and the longest distance 
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of SCs migration reached 5.0 mm, which occurred along the enlarged central canal. Grafted 
SCs-GFP myelinated axons within the lesion site and expressed P0 and MBP at 12 wk post-
transplantation. Except for a significant decrease of angle of rotation in footprint analysis, 
however, no significant behavioral improvements were observed in BBB locomotor rating 
scale, thermal withdrawal latency, footfall errors, and other parameters of foot print analysis 
in the SCs-GFP transplanted group as compared to the non-transplanted group. We conclude 
that grafted SCs-GFP survive, proliferate, migrate (to a limited extent in rostrocaudal 
orientation), and myelinate regenerated axons within the lesion site. Combining SC 
transplantation with other optimal strategies, however, is essential to achieve a more 
meaningful functional regeneration after SCI. This study has, for the first time, provided 
direct evident that long-term survival of grafted SCs is possible and practicable in a model 
of contusive SCI.
Survival of grafted cells is extremely important for cell transplantation-based therapy. The 
key finding of the current study was that grafted SCs-GFP survived remarkably well for at 
least 24 wk (approximately 6 mo) post-grafting. The longest survival was observed at 1 y 
post-transplantation even without using an immunosuppressant in the last 9 mo. Our 
observation was different from previous studies by Hill et al. reporting a 78% reduction in 
SC number within the first week after SC transplantation predominantly by necrosis (Hill et 
al., 2010; Hill et al., 2007). When comparing these studies to ours, four evident differences 
exist. First, the current study used passage 2 SCs for transplantation whereas the previous 
studies used passage 3 SCs. Second, the current study used two SC mitogens, i.e. forskolin 
and pituitary extract in the culture and in the transplantation medium, whereas the previous 
studies used three mitogens, i.e. forskolin, pituitary extract, and heregulin in the culture. 
Third, in the current study, all animals received a daily subcutaneous injection of CsA 
starting at 3 d prior to the transplantation and continued until the end of the experiments; 
whereas, in the previous study, the application of an immunosuppressive drug was not 
mentioned (Hill et al., 2007). Lastly, in the current study, SCs were isolated from adult 
transgenic rats expressing GFP, whereas, in the previous studies, SCs were isolated from 
Fisher 344 rats transduced with lentiviruses expressing GFP. While all grafted SCs in our 
case expressed GFP, only a subpopulation of SCs in their case might express GFP 
depending on the transduction efficiency of the virus. Therefore, different survival 
prognoses of grafted SCs may be caused by the fact that we counted all SCs including 
proliferating SCs that were GFP positive, whereas, they counted only lenti-GFP transduced 
SCs, leaving untransduced SCs not counted. Although the transduction efficiency in the SC 
cultures was > 99% as reported, it was difficult to know what percentage of SCs remained 
GFP positive in vivo especially after several days and weeks of survival at the lesion site.
It should be noted that ongoing cytotoxic processes within the contusion environment are 
harmful to the grafted cells. These processes include excitotoxicity, oxidative stress, 
inflammation, proteolysis, and anoxic damage, which are all components of progressive 
secondary injury (Amar and Levy, 1999; Tator and Fehlings, 1991). It is possible that in the 
Hill et al. study, lentiviral-transfected SCs might be more vulnerable to these damaging 
processes compared to non-transfected SCs, which then led to a decrease in proliferation and 
an increase in their sensitivity to these cytotoxic events. Additionally, cell-free lentiviral 
vectors might affect the microenvironment surrounding the grafted SCs to increase the 
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complexity of assessment. Finally, we cannot exclude the possibility that SCs derived from 
GFP rats in our case may have unknown alternative properties that make their survival in the 
lesion area feasible. Additionally, examination of strategies to enhance transplant survival in 
other models has demonstrated that the survival of transplanted cells is affected by not only 
post-graft interval and the site of grafting, but also by how cells are prepared before grafting 
(Sortwell, 2003). In the current study we treated the SCs-GFP culture medium with fresh 
mitogens at 4 h before cell collection. This approach may be advantageous to ensure that the 
cells were at optimal growth condition to resist injury-induced inflammatory environment 
after being transplanted into the lesion site.
Necrosis and apoptosis are two main contributors to death of transplanted cells. Although 
we did not examine the necrotic death profile of SCs-GFP post transplantation, our TUNEL 
staining showed that only a few grafted SCs-GFP underwent apoptosis 1 d after 
transplantation with no detected apoptosis thereafter. The low occurrence of apoptosis post-
transplantation could be a critical factor and supporting evidence that the majority of grafted 
SCs-GFP survived well for a prolonged period following transplantation. Contrast to the 
present study, lentiviral transduction of SCs underwent heavy necrosis, and apoptosis 
especially, within 1 wk following transplantation (Hill et al., 2007). This is not surprising 
because vector-related toxicity caused by the envelope protein has been reported by several 
studies (Power et al., 2004; Yang et al., 2007).
Proliferation of grafted SCs could be another important contributing factor for the presence 
of a large quantity of SCs-GFP at the lesion site after transplantation. Here we clearly 
demonstrated, for the first time, that grafted SCs were highly proliferative before they 
differentiated and myelinated axons at the lesion site. Fresh medium containing 10% FBS 
and 2 mitogens, pituitary extract and forskolin, were applied to the culture system prior to 
and during cell collection. This might boost the initial proliferation of SCs-GFP that we 
observed at 1 d after transplantation. Mostly impressively, the proliferation rate reached as 
high as 26% at 2 wk post-transplantation (Fig. 3C, G). This was consistent with the higher 
number of SCs-GFP found at 2 wk post-transplantation (Fig. 2O), indicating that 
proliferation contributed to an overall increase in the total number of SCs-GFP at this time 
point. The cell number increased by proliferation might also compensate for the cell loss 
induced by necrosis and/or apoptosis. The dynamic balance between cell survival and death 
might finally lead to a stable SCs-GFP cell number over a prolonged post-transplantation 
period. It should be noted that the time course of SCs-GFP proliferation occurred in a time 
window when host axons vigorously grew into the transplant. In a previous study, when SCs 
were seeded into a semipermeable guidance channel which was then transplanted into a 
right-sided spinal hemisection, anterogradely traced propriospinal axons grew into the graft 
prior to 2 d post-transplantation and approached the caudal host-graft interface at 14 d (Hsu 
and Xu, 2005), correlating well with the time course of SCs-GFP proliferation seen in the 
present study.
To maintain a long term survival of grafted cells, reestablishment of blood supply to 
regenerative tissue is essential. We therefore examined whether or not new blood vessels 
were formed within the graft environment. We found that new blood vessels, 
immunolabeled with REAC, grew into the SC graft as early as 1 wk after transplantation and 
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integrated well with the graft tissue throughout the entire survival period that was studied 
(24 wk, Fig. 7). The newly formed blood vessels may provide nutrition and trophic support 
for the survival of grafted SCs-GPF and axons within this region.
For allogeneic SC transplantation, an immune response to grafted cells exists and 
administration of an immunosuppressant could enhance the survival of grafted allogeneic 
SCs (Hill et al., 2006). We confirmed this observation in two ways. First, pretreatment and 
daily application of an immunosuppressant CsA led to remarkable SCs survival for a 
considerable period of time (up to 24 wk) after transplantation. In the CsA-treated spinal 
cord, only a small number of macrophages were found surrounding the transplants. 
Secondly, stopping the application of CsA after the 3rd month in the 1 y survival group 
resulted in massive invasion of ED1+ microphages within and surrounding the SCs-GFP 
graft. The phagocytic macrophages, containing engulfed debris of SCs-GFP (therefore 
became fluorescent green), migrated from the original graft site into the host tissue and 
evenly distributed throughout the host spinal cord close to the lesion (Fig. 9A). In addition, 
the marker label on the SCs in the Hill study was human placental alkaline phosphatase 
which could have engendered an immune response. Indeed, survival of these SCs was 
enhanced by immunosuppression with cyclosporine (Hill et al., 2006) The transgenic GFP 
label of SCs in the current study may have been much less immunogenic. These results 
emphasize the importance of using immunosuppressive agents in cell-based therapies in the 
preclinical and clinical settings.
SCs-GFP grafts decreased the angle of rotation of hindlimbs. This finding is in correlation 
with our observations that SC grafts resulted in a higher number of propriospinal or 
supraspinal axons regenerating into SCs-GFP grafts and SCs-GFP myelinated these 
regenerating or sprouted axons at the lesion site. It was shown previously that hindlimb 
recovery after an incomplete SCI depends on the number of spared and regenerated 
descending axons from brainstem nuclei and cerebral cortex (Basso et al., 1996; Saruhashi 
and Young, 1994) and from local propriospinal axons (Helgren and Goldberger, 1993). 
Interestingly, although decreased angle of rotation of hindlimb was observed in this study, 
we did not observe significant differences in BBB score, footfall error, paw withdrawal 
latency, total spread, paw length, stride length, and base of support between the SCs-GFP 
transplantation and non-transplantation groups. These results indicate that transplantation of 
SCs into the lesion gap may not be sufficient to promote substantial recovery of function. 
Additional strategies, including the activation of SCs prior to the transplantation or 
combining SC transplantation with other novel strategies such as increasing neuronal 
intrinsic capability for regeneration or exercise training, are required to promote meaningful 
functional recovery.
Just recently, the Miami Project to Cure Paralysis at University of Miami Miller School of 
Medicine received permission from the Food and Drug Administration (FDA) to begin a 
Phase I clinical trial to evaluate the safety of transplanting human autologous SCs to treat 
patients with spinal cord injuries. This is the only FDA-approved cell therapy-based clinical 
trial for sub-acute SCI in the United States (Xu, 2012). This study is certainly an important 
step towards applying cell-based therapies for patients with SCIs. Based on the findings of 
the present study, we believe the approved autologous Schwann cells transplantation trial is 
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a practicable and promising cell based therapy. To achieve meaningful functional recovery, 
it is likely that SC transplantation can be combined with other optimal strategies such as co-
transplantation with other cell candidates (Hu et al., 2013), reconstruction of growth-
promoting pathways through and beyond a lesion gap (Deng et al., 2013), or induction of 
intrinsic regenerative capacity of axons to regenerate (Liu et al., 2010).
Acknowledgments
We thank Ms. Lili Zhang for her assistance on animal behavior tests and Ms. Patti Raley, a medical editor, for her 
critical reading of the manuscript. This work was supported in part by National Institutes of Health (NIH) 1R01 
NS052290, NS052290-06S1, NS059622, NS050243, the Indiana Clinical and Translational Sciences Institute 
(CTSI) Collaboration in Biomedical/Translational Research (CBR/CTR) Pilot Program Grants (Grant #RR025761) 
from the NIH, the Indiana Spinal Cord and Brain Injury Research Foundation (ISCBIRF, A70-3-079793) and Mari 
Hulman George Endowment Funds.
References
Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in 
acute spinal cord injury. Neurosurgery. 1999; 44:1027–1039. [PubMed: 10232536] 
Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field 
testing in rats. J Neurotrauma. 1995; 12:1–21. [PubMed: 7783230] 
Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord 
contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996; 139:244–256. 
[PubMed: 8654527] 
Bradbury EJ, Khemani S, King VR, Priestley JV, McMahon SB. NT-3 promotes growth of lesioned 
adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur J Neurosci. 1999; 
11:3873–3883. [PubMed: 10583476] 
Bradbury EJ, McMahon SB. Spinal cord repair strategies: why do they work? Nat Rev Neurosci. 2006; 
7:644–653. [PubMed: 16858392] 
Cao QL, Howard RM, Dennison JB, Whittemore SR. Differentiation of engrafted neuronal-restricted 
precursor cells is inhibited in the traumatically injured spinal cord. Exp Neurol. 2002; 177:349–359. 
[PubMed: 12429182] 
Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration 
after spinal cord injury in rats and monkeys. Nat Med. 1997; 3:73–76. [PubMed: 8986744] 
Deng LX, Deng P, Ruan Y, Xu ZC, Liu NK, Wen X, Smith GM, Xu XM. A novel growth-promoting 
pathway formed by GDNF-overexpressing Schwann cells promotes propriospinal axonal 
regeneration, synapse formation, and partial recovery of function after spinal cord injury. J 
Neurosci. 2013; 33:5655–5667. [PubMed: 23536080] 
Deng LX, Hu J, Liu N, Wang X, Smith GM, Wen X, Xu XM. GDNF modifies reactive astrogliosis 
allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal 
cord injury. Exp Neurol. 2011
Ding Y, Yan Q, Ruan JW, Zhang YQ, Li WJ, Zeng X, Huang SF, Zhang YJ, Wang S, Dong H, Zeng 
YS. Bone marrow mesenchymal stem cells and electroacupuncture downregulate the inhibitor 
molecules and promote the axonal regeneration in the transected spinal cord of rats. Cell 
Transplant. 2011; 20:475–491. [PubMed: 20887664] 
Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, Geraghty T, Mackay-Sim A. 
Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005; 
128:2951–2960. [PubMed: 16219671] 
Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev 
Neurosci. 2003; 4:703–713. [PubMed: 12951563] 
Fujimoto Y, Abematsu M, Falk A, Tsujimura K, Sanosaka T, Juliandi B, Semi K, Namihira M, 
Komiya S, Smith A, Nakashima K. Treatment of a Mouse Model of Spinal Cord Injury by 
Transplantation of Human iPS Cell-derived Long-term Self-renewing Neuroepithelial-like Stem 
Cells. Stem Cells. 2012
Wang and Xu Page 14
Exp Neurol. Author manuscript; available in PMC 2015 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Girard C, Bemelmans AP, Dufour N, Mallet J, Bachelin C, Nait-Oumesmar B, Baron-Van Evercooren 
A, Lachapelle F. Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced 
primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J 
Neurosci. 2005; 25:7924–7933. [PubMed: 16135749] 
Gruner JA. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma. 1992; 9:123–
128. [PubMed: 1404425] 
Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring 
thermal nociception in cutaneous hyperalgesia. Pain. 1988; 32:77–88. [PubMed: 3340425] 
Helgren ME, Goldberger ME. The recovery of postural reflexes and locomotion following low 
thoracic hemisection in adult cats involves compensation by undamaged primary afferent 
pathways. Exp Neurol. 1993; 123:17–34. [PubMed: 8405276] 
Hill CE, Guller Y, Raffa SJ, Hurtado A, Bunge MB. A calpain inhibitor enhances the survival of 
Schwann cells in vitro and after transplantation into the injured spinal cord. J Neurotrauma. 2010; 
27:1685–1695. [PubMed: 20568964] 
Hill CE, Hurtado A, Blits B, Bahr BA, Wood PM, Bartlett Bunge M, Oudega M. Early necrosis and 
apoptosis of Schwann cells transplanted into the injured rat spinal cord. Eur J Neurosci. 2007; 
26:1433–1445. [PubMed: 17880386] 
Hill CE, Moon LD, Wood PM, Bunge MB. Labeled Schwann cell transplantation: cell loss, host 
Schwann cell replacement, and strategies to enhance survival. Glia. 2006; 53:338–343. [PubMed: 
16267833] 
Hill CE, Proschel C, Noble M, Mayer-Proschel M, Gensel JC, Beattie MS, Bresnahan JC. Acute 
transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, 
differentiation, and effects on lesion environment and axonal regeneration. Exp Neurol. 2004; 
190:289–310. [PubMed: 15530870] 
Hsu JY, Xu XM. Early profiles of axonal growth and astroglial response after spinal cord hemisection 
and implantation of Schwann cell-seeded guidance channels in adult rats. J Neurosci Res. 2005; 
82:472–483. [PubMed: 16240391] 
Hu J, Zhou J, Li X, Wang F, Lu H. Schwann cells promote neurite outgrowth of dorsal root ganglion 
neurons through secretion of nerve growth factor. Indian J Exp Biol. 2011; 49:177–182. [PubMed: 
21452596] 
Hu JG, Wang XF, Deng LX, Liu NK, Gao X, Chen JH, Zhou FC, Xu XM. Co-transplantation of glial 
restricted precursor cells and Schwann cells promotes functional recovery after spinal cord injury. 
Cell Transplant. 2013
Iannotti C, Li H, Yan P, Lu X, Wirthlin L, Xu XM. Glial cell line-derived neurotrophic factor-enriched 
bridging transplants promote propriospinal axonal regeneration and enhance myelination after 
spinal cord injury. Exp Neurol. 2003; 183:379–393. [PubMed: 14552879] 
Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I, Tedeschi A, Park KK, Jin D, Cai 
B, Xu B, Connolly L, Steward O, Zheng B, He Z. PTEN deletion enhances the regenerative ability 
of adult corticospinal neurons. Nat Neurosci. 2010; 13:1075–1081. [PubMed: 20694004] 
Liu XZ, Xu XM, Hu R, Du C, McDonald JW, Dong HX, Wu YJ, Fan GS, Jacquin MF, Hsu CY, Choi 
DW. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci. 1997; 17:5395–
5406. [PubMed: 9204923] 
Liu Y, Wang X, Lu CC, Kerman R, Steward O, Xu XM, Zou Y. Repulsive Wnt signaling inhibits axon 
regeneration after CNS injury. J Neurosci. 2008; 28:8376–8382. [PubMed: 18701700] 
Ma YH, Zhang Y, Cao L, Su JC, Wang ZW, Xu AB, Zhang SC. Effect of neurotrophin-3 genetically 
modified olfactory ensheathing cells transplantation on spinal cord injury. Cell Transplant. 2010; 
19:167–177. [PubMed: 20350361] 
Metz GAS, Merkler D, Dietz V, Schwab ME, Fouad K. Efficient testing of motor function in spinal 
cord injured rats. Brain Res. 2000; 883:165–177. [PubMed: 11074045] 
Mitsui T, Shumsky JS, Lepore AC, Murray M, Fischer I. Transplantation of neuronal and glial 
restricted precursors into contused spinal cord improves bladder and motor functions, decreases 
thermal hypersensitivity, and modifies intraspinal circuitry. J Neurosci. 2005; 25:9624–9636. 
[PubMed: 16237167] 
Wang and Xu Page 15
Exp Neurol. Author manuscript; available in PMC 2015 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Morrissey TK, Kleitman N, Bunge RP. Isolation and functional characterization of Schwann cells 
derived from adult peripheral nerve. J Neurosci. 1991; 11:2433–2442. [PubMed: 1869923] 
Oudega M, Xu XM. Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma. 
2006; 23:453–467. [PubMed: 16629629] 
Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous 
system. Curr Pharm Des. 2005; 11:1255–1265. [PubMed: 15853682] 
Power C, Zhang K, van Marle G. Comparative neurovirulence in lentiviral infections: The roles of 
viral molecular diversity and select proteases. J Neurovirol. 2004; 10(Suppl 1):113–117. [PubMed: 
14982749] 
Sandner B, Prang P, Rivera FJ, Aigner L, Blesch A, Weidner N. Neural stem cells for spinal cord 
repair. Cell Tissue Res. 2012
Saruhashi Y, Young W. Effect of mianserin on locomotory function after thoracic spinal cord 
hemisection in rats. Exp Neurol. 1994; 129:207–216. [PubMed: 7957735] 
Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004; 5:146–156. [PubMed: 
14735117] 
Sortwell CE. Strategies for the augmentation of grafted dopamine neuron survival. Front Biosci. 2003; 
8:s522–532. [PubMed: 12700087] 
Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, Bunge MB. Schwann cell but not olfactory 
ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused 
adult rat thoracic spinal cord. J Neurosci. 2002; 22:6670–6681. [PubMed: 12151546] 
Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with 
emphasis on vascular mechanisms. J Neurosurg. 1991; 75:15–26. [PubMed: 2045903] 
Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci. 
2006; 7:628–643. [PubMed: 16858391] 
Totoiu MO, Keirstead HS. Spinal cord injury is accompanied by chronic progressive demyelination. J 
Comp Neurol. 2005; 486:373–383. [PubMed: 15846782] 
Xu XM. Roles of Schwann cells in the repair and regeneration of the central nervous system. Chinese J 
Neuroanat. 1996; 12:291–302.
Xu XM, Chen A, Guenard V, Kleitman N, Bunge MB. Bridging Schwann cell transplants promote 
axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J 
Neurocytol. 1997; 26:1–16. [PubMed: 9154524] 
Xu XM, Guenard V, Kleitman N, Aebischer P, Bunge MB. A combination of BDNF and NT-3 
promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. 
Exp Neurol. 1995a; 134:261–272. [PubMed: 7556546] 
Xu XM, Guenard V, Kleitman N, Bunge MB. Axonal regeneration into Schwann cell-seeded guidance 
channels grafted into transected adult rat spinal cord. J Comp Neurol. 1995b; 351:145–160. 
[PubMed: 7896937] 
Xu XM, Onifer SM. Transplantation-mediated strategies to promote axonal regeneration following 
spinal cord injury. Respir Physiol Neurobiol. 2009; 169:171–182. [PubMed: 19665611] 
Yang SH, Agca Y, Cheng PH, Yang JJ, Agca C, Chan AW. Enhanced transgenesis by 
intracytoplasmic injection of envelope-free lentivirus. Genesis. 2007; 45:177–183. [PubMed: 
17417786] 
Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 2006; 7:617–627. 
[PubMed: 16858390] 
Wang and Xu Page 16
Exp Neurol. Author manuscript; available in PMC 2015 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Highlights
• We assessed the fate and temporal profile of grafted Schwann cells (SCs) 
overexpressing GFP in a contusive spinal cord injury (SCI).
• Grafted SCs showed a remarkable survival up to 24 wk post-grafting.
• Grafted SCs proliferated and the proliferation peaked at 2 wk post-
transplantation.
• Grafted SCs facilitated new blood vessels formation within the lesion site.
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Fig. 1. 
Experimental design and Schwann cells overexpressing green fluorescent protein (SCs-GFP) 
culture in vitro. A: Schwann cell isolated from the sciatic nerves of the adult transgenic rats 
strongly expressed GFP and expanded to form a confluence layer in culture. One week after 
spinal cord injury, these cells were transplanted into the epicenters of injured spinal cords 
and continued to observe the survival, proliferation, apoptosis, migration, and myelination of 
SCs (Exp. 1), the long-term fate of SCs (Exp. 2) and behavioral changes over time (Exp. 3). 
Immunocytochemistry showed that over 98% of these SCs-GFP cells (B, green) express P75 
neurotrophic factor receptor (P75NTR, C, red), a specific marker for Schwann cells (D). 
Scale bars = 20 μm.
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Fig. 2. 
Survival of grafted Schwann cells overexpressing green fluorescent protein (SCs-GFP) up to 
24 wk post-transplantation in vivo. Representative fluorescence photomicrographs of 
longitudinal sections of the spinal cord showing that SCs-GFP survived remarkably well at 5 
min (A), 1 d (B), 1 wk (C), 2 wk (D), 4 wk (E), 12 wk (F), and 24 wk (G) post-
transplantation. The surviving SCs-GFP were evenly distributed at the lesion site and were 
surrounded by GFAP+ host tissue (stained in red). H–N shows the detailed morphology of 
SCs-GFP at different post-transplantation time points corresponding to A–F. Note that when 
SCs were initially grafted into the lesion cavity, they exhibited rounded morphology (H). 
These cells extended their processes (I) and arranged in an orderly manner (J–N) likely in 
accordance with the growth of axons into the graft region. O: Quantification of the number 
of SCs-GFP at different time points shows the remarkable survival of these cells up to 24 wk 
post-transplantation. *, p<0.05, **, p<0.01. Scale bar: A–G, 200 μm; H–N, 20 μm.
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Fig. 3. 
Proliferation of grafted Schwann cells overexpressing green fluorescent protein (SCs-GFP) 
at different time points post-transplantation. An intraperitoneal injection of 100 mg/kg BrdU 
was performed every 6 h, 1 d before animal perfusion. A–G: Proliferation of SCs-GFP 
(double labeled with BrdU & GFP, arrows) was observed as early as 1 d post-transplantation 
and it reached the maximum at 2 wk post-transplantation. H: The proliferation rate of SCs-
GFP (GFP+BrdU+Hoechst+/GFP+Hoechst+) was about 5.47±0.84% at 1 d. Compared to day 
1 this proliferation rate increased 1 wk (9.54±1.23%, χ2=24708, p<0.001), peaked at 2 wk 
(25.91±2.21, χ2=402136, p<0.001), decreased at 4 wk (6.13±0.49%, χ2=815, p<0.001), and 
stopped at 12 wk (0.07±0.00%, χ2=80570, p<0.001) and 24 wk (E) post-transplantation. 
Scale bar = 25 μm.
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Fig. 4. 
Apoptosis of grafted Schwann cells overexpressing green fluorescent protein (SCs-GFP) at 
different time points post-transplantation. A–G: Very few grafted SCs-GFP were underwent 
apoptosis. A representative TUNEL+ Schwann cell (GFP+) was shown at 5 min post-
transplantation (A, arrow). H: Percent apoptosis of grafted SCs at different time points. Very 
few SCs-GFP were found to be apoptotic at 5 min (0.17%) and 1 d (0.03%) post-
transplantation. No TUNEL+ cells were detected between 1 wk and 24 wk post-
transplantation. Scale bar = 25 μm.
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Fig. 5. 
Migration of grafted Schwann cells overexpressing green fluorescent protein (SCs-GFP) 
post-transplantation. A: At 1 d post-transplantation, GFP-SCs formed radiating processes 
attempting to extend from the graft into the host spinal cord. A′ is a high magnification of 
boxed area in A clearly showing the migratory attempt of SCs-GFP. B,C: 4 wk post-
transplantation, GFP-SCs were mainly confined within a well-defined graft-host interface 
that surrounded the grafted cells. At the rostral graft-host interface, migration of SCs-GFP 
from the lesion border (yellow dashed line) into the host tissue was found for a distance of 
3.0 mm (B) and 5.0 mm (C). B′ and C′, are higher magnification of boxed areas in B and C. 
Scale bar: A–C, 200 μm; A′–C′, 20 μm.
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Fig. 6. 
Myelination of grafted Schwann cells overexpressing green fluorescent protein (SCs-GFP) 
post-transplantation. A: Immunofluorescence staining demonstrated that grafted SCs-GFP 
were in close association with axons growing into the graft at 4 wk post-transplantation 
(arrow). B–D: A longitudinal section shows that a SC established a one-on-one relationship 
with a single axon immunostained with SMI-31+ (arrows). E–G: A cross section shows that 
numerous SCs (arrows) wrapped axons (SMI-31+) within the graft region. H–O: Myelinated 
axons expressed myelin markers P0 (H–K, arrows) and MBP (L–O, arrows) at 3 mo post-
transplantation. Scale bar: A, 40 μm; B–G, 20 μm; H–O, 10 μm.
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Fig. 7. 
Blood vessel supply to the Schwann cells (SCs) transplants. A: In a control case that 
received a contusive spinal cord injury (SCI) without SCs-GFP transplantation, a well-
defined cystic cavity was formed at 3 mo post-injury and REAC+ blood vessels were 
observed only in host tissues surrounding the lesion cavity. B: In contrast, many REAC+ 
blood vessels were found within the SCs-GFP graft at 3 mo post-transplantation. C–J: High 
magnifications show the REAC+ blood vessel staining at the lesion border in a control case 
(C), the lack of blood vessels within the graft at 5 min (D) and 1 d (E) post-transplantation, 
the first appearance of blood vessels within the graft at 1 wk post-transplantation (F), and 
increased blood vessels were observed at 2 (G), 4 (H), 12 (I), and 24 (J) wk post-
transplantation. Scale bar: A–B, 200 μm; C–J, 20 μm.
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Fig. 8. 
Locomotor and sensory outcomes after Schwann cells overexpressing green fluorescent 
protein (SCs-GFP) transplantation. A–C: Up to 10 wk post-transplantation, no statistically 
significant differences in BBB locomotor rating scale (A), footfall errors (B) and paw 
withdrawal latency (C) were found between the SCs-GFP transplantation and control 
groups. D–H: For footprint analysis, significant improvement between the 2 groups was 
found only in the angle of rotation (D) but not in the total spread (E), paw length (F), stride 
length (G), and base of support (H). *, p<0.05.
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Fig. 9. 
Survival of grafted Schwann cells overexpressing green fluorescent protein (SCs-GFP) up to 
1 y. A–B: Survival of SCs-GFP at 1 y post-transplantation. In these animals, the 
immunosuppressant cyclosporine A (CsA) was used for the first 3 mo and then withdrawn. 
Numerous SCs-GFP survived up to 1 y, which could be appreciated at higher magnification 
(B) of the boxed area of A. Numerous GFP-labeled phagocytes were also found remote to 
the graft site (arrows, A) indicating that macrophages might have engulfed degenerated SCs-
GFP and migrated away from the graft site. C–F: Triple labeling of GFP (arrowheads, C), 
hoechst (arrowheads, D) and ED1+ (arrowheads, E, a marker for macrophages) confirmed 
that macrophages engulfed debris of degenerated SCs-GFP and then became fluorescent 
green. Scale bar: A, 500 μm; B, 100 μm; C–F, 50 μm.
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